Fresenius Medical Care SA with ticker code (FMS) now have 5 total analysts covering the stock. The consensus odds are “Hold”. The range between the high target price and the low target price is between 46.08 and 35.46 by calculating the average target price that we have 40.96. With the stock’s previous close at 35.26, this indicates that there is a potential upside of 16.2%. There is a 50-day moving average of 37.55 and the 200 moving average now drops to 39.31. The company’s market capitalization is $ 20,661 million. For more information, visit: http://www.freseniusmedicalcare.com
Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America and abroad. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; equipment, training and patient support services including clinical monitoring, follow-up assistance and organization of delivery of supplies to the patient’s home; and contract dialysis services with hospitals in the United States for inpatients with end-stage renal disease (ESRD) and for patients with acute kidney disease. The company also develops, manufactures and distributes dialysis products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granules, blood lines, renal pharmaceuticals and water treatment systems; and products other than dialysis, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires and licenses renal pharmaceuticals; provides medications and kidney supplies to patients at home or at dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, outpatient vascular care surgery center, and physician nephrology and cardiology services. The company sells its products directly to dialysis clinics, hospitals and specialty treatment clinics, as well as through local sales forces, independent distributors, resellers and sales agents. As of December 31, 2020, it operated 4,092 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.
You can now share this on Stocktwits, just click on the logo below and add the ticker in the text to be seen.